Court accepts Hugel’s request to suspend revocation of product licenses The achievement highlights the pharmaceutical company's risk management capabilities
Translated by Ryu Ho-joung 공개 2021-12-23 08:18:46
이 기사는 2021년 12월 21일 06:54 thebell 에 표출된 기사입니다.
South Korean botox maker Hugel has obtained a court order allowing it to continue to sell its botulinum toxin products regulated by the country’s Ministry of Food and Drug Safety for now, clearing a hurdle ahead of its planned acquisition by a GS Group-led consortium.On Friday, the Seoul Administrative Court accepted the company’s request to suspend the MFDS’ decision. In November, the authority said it would revoke licenses of four botox products made by Hugel for failing to get necessary approval to supply them domestically, and ordered the company to recall and dispose of them.
Hugel immediately released a statement saying that transactions regulated by the MFDS were made to export the products, which is not subject to domestic regulations.
With Friday’s court decision, the license revocation, which took effect December 13, will be nullified until the main case filed by Hugel against the MFDS is resolved.
Hugel is set to change hands after a consortium led by South Korean conglomerate GS Group signed a deal to buy a controlling stake in the pharmaceutical company from private equity firm Bain Capital this summer.
Earlier this month, the deal received a nod from the country’s trade ministry, which concluded that the acquisition poses no concern of technology leaks. Many expect the deal to close before the deadline of January 12, 2022.
Hugel’s dealings with the MFDS highlight its strong risk management capabilities, industry watchers said. Hugel also obtained licenses for its botox products from Chinese health authorities last year to become the first such company in South Korea. This was an achievement by the company which sought to expand into global markets amid cutthroat competition among domestic botox makers.
“We are not shaken by the acquisition process and other issues and continue to focus on increasing our competitiveness,” an official at Hugel said. “We will also increase shareholder value by retiring treasury shares and paying dividends.” (Reporting by Eun-su Choi)
< 저작권자 ⓒ 자본시장 미디어 'thebell', 무단 전재, 재배포 및 AI학습 이용 금지 >
관련기사
best clicks
최신뉴스 in 전체기사
-
- [캐시플로 모니터]현금창출력 저하 SK케미칼, 3년째 '순현금' 유지 배경은
- 발전 자회사 관리 맡은 윤병석 SK가스 사장, SKMU 의장 겸직
- [LG화학의 변신]배터리 사업 분할 이후 4년, 뭘 얻었을까
- [방산기업 국산화율 톺아보기]'지상에선 100%, 하늘에선 유일무이' 한화에어로
- [한솔그룹은 지금]'군계일학' 한솔아이원스, 홀로 돋보인 주가 상승
- [Peer Match Up/정유 4사]주주환원에 적극적인 정유사...전략은 제각각
- [이사회 분석]이사진 절반 새 얼굴 LX MMA, 적자 탈출 시동
- 이엔플러스, 글로벌 셀메이커 방열 소재 사용 승인
- [아시아나 화물사업부 M&A]본입찰 마감, 제주항공 불참
- 크라우드웍스, 비즈니스 특화 소형언어모델 ‘웍스원’ 개발